drug

ivacaftor

1 story · latest Oct 15, 2026

Follow ivacaftor. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jan 2012 · NDA203188, NDA207925
Brand: Kalydeco

Relationships

Developed by Vertex Pharmaceuticals Inc / Ma

Timeline

Vertex posts Phase 3 results for ELX/TEZ/IVA in CF infants 12 to 24 months

Oct 15Trial updateivacaftor Vertex Pharmaceuticals Inc / Ma

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.